CG Oncology Inc header image

CG Oncology Inc

CGON

Equity

ISIN US1569441009 / Valor 131996952

NASDAQ (2024-09-18)
USD 37.06-1.83%

CG Oncology Inc
UMushroom community rating:

star star star star star
0.00 0 votes No rating yet
NegativeNeutralPositive

About company

CG Oncology Inc. is a late-stage clinical biopharmaceutical company dedicated to the development and commercialization of oncolytic immunotherapies for bladder cancer. The company's primary investigational drug, cretostimogene, is designed to treat BCG-unresponsive, Non-Muscle Invasive Bladder Cancer (NMIBC). Although not yet approved by any regulatory agency, cretostimogene has demonstrated clinical benefits and has been generally well-tolerated in clinical trials, both as a monotherapy and in combination with other treatments. CG Oncology aims to provide innovative therapeutic options that enhance the quality of life for patients with urologic cancers.

Summarized from source with an LLMView SourceSector: Healthcare

Latest Results ():

Summarized from source with an LLMView Source

Key figures

%1Y
%3Y
%5Y

Performance

73.0%1Y
73.0%3Y
73.0%5Y

Volatility

Market cap

2486 M

Market cap (USD)

Daily traded volume (Shares)

677,392

Daily traded volume (Shares)

1 day high/low

38.1 / 36.54

1 day high/low (USD)

52 weeks high/low

0.00 / 0.00

52 weeks high/low (USD)

Dividend ex-date

01 January, 2022

Dividend ex-date

Dividend

0.00

Dividend (USD)

Dividend yield (p.a.)

0.00%

Dividend yield (p.a.)

0.002022
0.002023
0.002024

Est dividend (USD)

0.00%2022
0.00%2023
0.00%2024

Est dividend yield

P/E ratio

10.00

P/E ratio

00.002022
00.002023
00.002024

Est P/E ratio

EPS

0.00

EPS (USD)

0.002022
0.002023
0.002024

Est EPS (USD)

Ratings & reviews

star star star star star

0.00

0 votes
Performance:
starstarstarstarstar
0.00
Innovation:
starstarstarstarstar
0.00
Society:
starstarstarstarstar
0.00
Nature:
starstarstarstarstar
0.00

EQUITIES OF THE SAME SECTOR

Emeis
Emeis Emeis Valor: 132546338
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-1.00%EUR 7.23
Tempus AI Inc
Tempus AI Inc Tempus AI Inc Valor: 135855934
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
4.23%USD 51.31
Zoetis Inc
Zoetis Inc Zoetis Inc Valor: 19276994
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
0.39%USD 196.48
Novartis Inc
Novartis Inc Novartis Inc Valor: 1200526
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
0.01%CHF 98.04
Sonova Holding Ltd.
Sonova Holding Ltd. Sonova Holding Ltd. Valor: 1254978
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-2.29%CHF 295.00
Tecan Group Ltd.
Tecan Group Ltd. Tecan Group Ltd. Valor: 1210019
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
0.07%CHF 278.40
Galenica Ltd.
Galenica Ltd. Galenica Ltd. Valor: 36067446
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-0.88%CHF 72.90
Idorsia Ltd
Idorsia Ltd Idorsia Ltd Valor: 36346343
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-3.61%CHF 1.52
AEVIS VICTORIA SA
AEVIS VICTORIA SA AEVIS VICTORIA SA Valor: 47863410
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
2.19%CHF 14.00
COSMO Pharmaceuticals N.V.
COSMO Pharmaceuticals N.V. COSMO Pharmaceuticals N.V. Valor: 32590356
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-1.40%CHF 77.20